Storia in 2 fonti

Study on GLP-1s and Breast Cancer 'Too Good to Be True'?

Lower mortality seen in observational study, but experts cast doubt on underlying data

Raccontata da

medpagetoday.com

healio.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 mesi fa

Study on GLP-1s and Breast Cancer 'Too Good to Be True'?

Lower mortality seen in observational study, but experts cast doubt on underlying data

originale

healio.com1 mesi fa

‘Encouraging’ signal: GLP-1s may help reduce breast cancer recurrence, improve survival

GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, results of a retrospective cohort study suggest.Women with breast cancer and obesity who used GLP-1…

Leggi questa versione → originale

Timeline cronologica

martedì 12 maggio 2026·medpagetoday.com
Study on GLP-1s and Breast Cancer 'Too Good to Be True'?
Lower mortality seen in observational study, but experts cast doubt on underlying data
giovedì 14 maggio 2026·healio.com
‘Encouraging’ signal: GLP-1s may help reduce breast cancer recurrence, improve survival
GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, results of a retrospective cohort study suggest.Women with…